Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal unveiled by the Biden administration. The White House stated that approximately 3.4 million Medicare beneficiaries and about 4 million Medicaid recipients would benefit from this initiative, potentially reducing out-of-pocket costs significantly for some Medicare enrollees.
The proposal aims to reinterpret the statute to allow coverage for the treatment of obesity as a chronic disease, acknowledging the medical community's consensus on obesity being a serious condition that can lead to various health issues. The Centers for Medicare and Medicaid Services highlighted that 22% of Medicare enrollees were diagnosed with obesity in 2022, emphasizing the need for expanded coverage.
